4//SEC Filing
Merck & Co., Inc. 4
Accession 0001225208-15-020026
$MRKCIK 0000310158operating
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:23 PM ET
Size
8.6 KB
Accession
0001225208-15-020026
Insider Transaction Report
Form 4
AMBROSE ADELE D
V-P & Chief Com. Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-10-29−37,313→ 0 totalExercise: $36.56From: 2012-05-04Exp: 2021-05-03→ Common Stock (37,313 underlying) - Exercise/Conversion
Common Stock
2015-10-29$36.56/sh+37,313$1,364,163→ 57,007.635 total - Sale
Common Stock
2015-10-29$55.08/sh−37,313$2,055,334→ 19,694.635 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.9100 to $55.1900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000310158
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:23 PM ET
- Size
- 8.6 KB